IDO and TDO as a potential therapeutic target in different types of depression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IDO and TDO as a potential therapeutic target in different types of depression
Authors
Keywords
IDO, TDO, Kynurenine pathway, Depression, IDO inhibitors, TDO inhibitors
Journal
METABOLIC BRAIN DISEASE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-16
DOI
10.1007/s11011-018-0290-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect
- (2018) Bo Wang et al. BEHAVIOURAL BRAIN RESEARCH
- The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
- (2018) Gislaine Z. Réus et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The molecular aspects of oxidative & nitrosative stress and the tryptophan catabolites pathway (TRYCATs) as potential causes of depression
- (2018) Paulina Wigner et al. PSYCHIATRY RESEARCH
- The Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression
- (2018) Nikoletta Dobos et al. JOURNAL OF ALZHEIMERS DISEASE
- Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis
- (2017) David Fraguas et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder
- (2017) Gislaine Z. Réus et al. LIFE SCIENCES
- Social stress induces neurovascular pathology promoting depression
- (2017) Caroline Menard et al. NATURE NEUROSCIENCE
- Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
- (2017) Eric Plitman et al. SCHIZOPHRENIA BULLETIN
- Serum kynurenic acid is reduced in affective psychosis
- (2017) B E Wurfel et al. Translational Psychiatry
- Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder
- (2016) Timothy B. Meier et al. BRAIN BEHAVIOR AND IMMUNITY
- Stress-Related Immune Markers in Depression: Implications for Treatment
- (2016) Martina M. Hughes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
- (2016) Jennifer L. Remus et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing Depressive Like Behavior in Rats
- (2016) Sally A. Abuelezz et al. Journal of Neuroimmune Pharmacology
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Theo Vos et al. LANCET
- Cerebral revascularization for the treatment of patients with acute ischemic stroke
- (2016) V. V. Krylov et al. Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova
- A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality
- (2015) Cecilie Bay-Richter et al. BRAIN BEHAVIOR AND IMMUNITY
- Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder
- (2015) Jonathan Savitz et al. BRAIN BEHAVIOR AND IMMUNITY
- Astrocyte and Microglial Control of Glutamatergic Signalling: A Primer on Understanding the Disruptive Role of Chronic Stress
- (2015) J. Mayhew et al. JOURNAL OF NEUROENDOCRINOLOGY
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients
- (2015) Ines Chevolet et al. MELANOMA RESEARCH
- Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes
- (2015) Isabella Caroline da Silva Dias et al. MOLECULAR NEUROBIOLOGY
- Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder
- (2015) Jonathan Savitz et al. PSYCHONEUROENDOCRINOLOGY
- Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
- (2015) Nicolas van Baren et al. Frontiers in Immunology
- T cell-NF-κB activation is required for tumor control in vivo
- (2015) Sarah E Barnes et al. Journal for ImmunoTherapy of Cancer
- Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition
- (2014) Cristina Gonzalez-Liencres et al. BMC Psychiatry
- Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
- (2014) Carolina Hoyo-Becerra et al. BRAIN BEHAVIOR AND IMMUNITY
- IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
- (2014) Richard Metz et al. INTERNATIONAL IMMUNOLOGY
- Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour
- (2014) Sinead M. Gibney et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- PlasmaL-Tryptophan Concentration in Major Depressive Disorder
- (2014) Shintaro Ogawa et al. JOURNAL OF CLINICAL PSYCHIATRY
- The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells
- (2014) S. Trabanelli et al. JOURNAL OF IMMUNOLOGY
- Effect of docosahexaenoic acid on hippocampal neurons in high-glucose condition: Involvement of PI3K/AKT/nuclear factor-κB-mediated inflammatory pathways
- (2014) R.-H. Yang et al. NEUROSCIENCE
- Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
- (2014) Jacqueline Quak et al. PSYCHONEUROENDOCRINOLOGY
- Biochemical and Neurotransmitters Changes Associated with Tramadol in Streptozotocin-Induced Diabetes in Rats
- (2014) Essam Ezzeldin et al. Biomed Research International
- Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease
- (2013) Amos A. Fatokun et al. AMINO ACIDS
- Antitumour agents as inhibitors of tryptophan 2,3-dioxygenase
- (2013) Georgios Pantouris et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tryptophan: The key to boosting brain serotonin synthesis in depressive illness
- (2013) Abdulla A-B Badawy JOURNAL OF PSYCHOPHARMACOLOGY
- The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1 and with increased CSF KYNA level and reduced KMO expression
- (2013) C Lavebratt et al. MOLECULAR PSYCHIATRY
- Connecting inflammation with glutamate agonism in suicidality
- (2013) Sophie Erhardt et al. NEUROPSYCHOPHARMACOLOGY
- Impact of inflammation on neurotransmitter changes in major depression: An insight into the action of antidepressants
- (2013) Brian E. Leonard PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
- (2013) Adrian L. Lopresti et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2
- (2012) Supun M. Bakmiwewa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
- (2012) Michael Maes et al. BMC Medicine
- Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX3CR1)-deficient mice
- (2012) Angela W. Corona et al. BRAIN BEHAVIOR AND IMMUNITY
- Kynurenines: from the perspective of major psychiatric disorders
- (2012) Aye M. Myint FEBS Journal
- Quinolinic acid, the inescapable neurotoxin
- (2012) Gilles J. Guillemin FEBS Journal
- Kynurenines in the CNS: recent advances and new questions
- (2012) László Vécsei et al. NATURE REVIEWS DRUG DISCOVERY
- Kynurenines in the mammalian brain: when physiology meets pathology
- (2012) Robert Schwarcz et al. NATURE REVIEWS NEUROSCIENCE
- 3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the Central Nervous System
- (2012) Ana Laura Colín-González et al. NEUROTOXICOLOGY
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
- (2012) L. Pilotte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway
- (2012) Michael Maes et al. PSYCHIATRY RESEARCH
- An expanding range of targets for kynurenine metabolites of tryptophan
- (2012) Trevor W. Stone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
- (2011) Ikwunga Wonodi ARCHIVES OF GENERAL PSYCHIATRY
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients
- (2011) A.M. Myint et al. BRAIN BEHAVIOR AND IMMUNITY
- Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators
- (2011) Eduard Dolušić et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of the kynurenine metabolism in major depression
- (2011) Aye-Mu Myint et al. JOURNAL OF NEURAL TRANSMISSION
- Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
- (2011) Johann Steiner et al. Journal of Neuroinflammation
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Diabetic neuropathy: cellular mechanisms as therapeutic targets
- (2011) Andrea M. Vincent et al. Nature Reviews Neurology
- Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
- (2011) Ebrahim Haroon et al. NEUROPSYCHOPHARMACOLOGY
- On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
- (2011) R. Lugo-Huitrón et al. NEUROTOXICOLOGY AND TERATOLOGY
- Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells
- (2010) Ting Sun et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors
- (2010) H. K. Koblish et al. MOLECULAR CANCER THERAPEUTICS
- Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C
- (2010) Stefano Comai et al. PHARMACOLOGICAL RESEARCH
- The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
- (2010) M. Maes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inflammation-associated depression: From serotonin to kynurenine
- (2010) Robert Dantzer et al. PSYCHONEUROENDOCRINOLOGY
- Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
- (2010) K. V. Sathyasaikumar et al. SCHIZOPHRENIA BULLETIN
- Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
- (2010) K. R. Linderholm et al. SCHIZOPHRENIA BULLETIN
- CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
- (2009) C L Raison et al. MOLECULAR PSYCHIATRY
- Effects of tryptophan loading on human cognition, mood, and sleep
- (2009) B.Y. Silber et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons
- (2009) Nady Braidy et al. NEUROTOXICITY RESEARCH
- IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
- (2008) Stefan Löb et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- COX-2 Inhibition in Schizophrenia and Major Depression
- (2008) Norbert Muller et al. CURRENT PHARMACEUTICAL DESIGN
- Examining a Bidirectional Association Between Depressive Symptoms and Diabetes
- (2008) Sherita Hill Golden JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
- (2008) J C O'Connor et al. MOLECULAR PSYCHIATRY
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started